Cano Health, Vacasa, Organogenesis, And Some Other Big Stocks Moving Lower On Thursday

U.S. stocks traded higher, with the Nasdaq surging more than 500 points on Thursday. Here are some big stocks recording losses in today’s session.

• Veru Inc. VERU tumbled 50.6% to $7.42 after the company reported that FDA’s Pulmonary-Allergy Drugs Advisory Committee voted 8-5 that the “known and potential benefits” of its sabizabulin in treating adult hospitalized COVID-19 patients at high risk of acute respiratory distress syndrome do not outweigh the “known and potential risks.”
• Edgio, Inc. EGIO declined 49.8% to $1.0850 after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates.
• Vacasa, Inc. VCSA dropped 38.6% to $2.20 after the company reported worse-than-expected Q3 EPS results.
• Cano Health, Inc. CANO shares declined 34% to $2.2050 after the company reported worse-than-expected Q3 EPS and sales results. Raymond James downgraded Cano Health from Outperform to Market Perform.
• EQRx, Inc. EQRX dipped 31.5% to $3.73 following Q3 earnings.
• Vigil Neuroscience, Inc. VIGL fell 30.5% to $8.56. Vigil Neuroscience posted a Q3 loss of $0.53 per share.
• Xometry, Inc. XMTR dropped 24.6% to $38.00 after the company issued weak sales forecast.
• Organogenesis Holdings Inc. ORGO fell 22.8% to $2.3850 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance below analyst estimates.
• Advantage Solutions Inc. ADV dropped 21.5% to $2.55 following weak quarterly sales.
• Trevena, Inc. TRVN fell 16.5% to $2.55. Trevena posted a Q3 loss of $0.09 per share.
• Azul S.A. AZUL dipped 14.7% to $7.51 following Q3 results.
• Montauk Renewables, Inc. MNTK dropped 14.3% to $11.04 following downbeat Q3 results.
• Chart Industries, Inc. GTLS fell 13.4% to $133.65.
• SunOpta Inc. STKL dropped 13.2% to $9.06 following Q3 results.
• TechTarget, Inc. TTGT fell 11.5% to $44.85 after the company reported worse-than-expected Q3 sales results. The company also issued Q4 and FY22 sales guidance below analyst estimates.
• PureCycle Technologies, Inc. PCT fell 10.4% to $6.42 following Q3 earnings.
• WeWork Inc. WE fell 6% to $2.2850 following downbeat Q3 results.